Connection

MIGUEL A RODRIGUEZ-BIGAS to Humans

This is a "connection" page, showing publications MIGUEL A RODRIGUEZ-BIGAS has written about Humans.
Connection Strength

0.566
  1. Primary Tumor Resection in Colorectal Cancer with Unresectable Synchronous Metastasis: Time to Reconsider the Role of the Surgeon. Ann Surg Oncol. 2022 01; 29(1):1-3.
    View in: PubMed
    Score: 0.016
  2. Anal Dysplasia. Surg Oncol Clin N Am. 2017 01; 26(1):33-43.
    View in: PubMed
    Score: 0.012
  3. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014 Jun; 109(7):652-8.
    View in: PubMed
    Score: 0.009
  4. Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome). Fam Cancer. 2013 Jun; 12(2):295-300.
    View in: PubMed
    Score: 0.009
  5. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
    View in: PubMed
    Score: 0.009
  6. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection. Surg Oncol Clin N Am. 2010 Oct; 19(4):847-59.
    View in: PubMed
    Score: 0.008
  7. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg. 2010 Feb; 251(2):261-4.
    View in: PubMed
    Score: 0.007
  8. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol. 2009 Dec 10; 27(35):5938-43.
    View in: PubMed
    Score: 0.007
  9. Role of surgery in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer (Lynch syndrome). Surg Oncol Clin N Am. 2009 Oct; 18(4):705-15.
    View in: PubMed
    Score: 0.007
  10. A twenty-year experience with adenocarcinoma of the anal canal. Dis Colon Rectum. 2009 Aug; 52(8):1375-80.
    View in: PubMed
    Score: 0.007
  11. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):824-30.
    View in: PubMed
    Score: 0.007
  12. Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care study from the national cancer data base. Ann Surg Oncol. 2008 Nov; 15(11):3036-47.
    View in: PubMed
    Score: 0.006
  13. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007 Aug; 246(2):215-21.
    View in: PubMed
    Score: 0.006
  14. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007 Jun; 14(6):1870-7.
    View in: PubMed
    Score: 0.006
  15. Barriers to rehabilitation of colorectal cancer patients. J Surg Oncol. 2007 Apr 01; 95(5):400-8.
    View in: PubMed
    Score: 0.006
  16. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol. 2006 May; 13(5):612-23.
    View in: PubMed
    Score: 0.005
  17. Surgical implications of colorectal cancer genetics. Surg Oncol Clin N Am. 2006 Jan; 15(1):51-66, vi.
    View in: PubMed
    Score: 0.005
  18. Type-2 dominant cytokine gene expression following hepatic surgery. J Hepatobiliary Pancreat Surg. 2006; 13(5):442-9.
    View in: PubMed
    Score: 0.005
  19. Pelvic reconstruction after abdominoperineal resection: is it worthwhile? Ann Surg Oncol. 2005 Feb; 12(2):91-4.
    View in: PubMed
    Score: 0.005
  20. Clinicopathologic features in colorectal cancer patients with microsatellite instability. Mutat Res. 2004 Dec 21; 568(2):275-82.
    View in: PubMed
    Score: 0.005
  21. Colorectal carcinogenesis: MSI-H versus MSI-L. Dis Markers. 2004; 20(4-5):199-206.
    View in: PubMed
    Score: 0.005
  22. Lynch syndrome: implications for the surgeon. Clin Colorectal Cancer. 2003 Aug; 3(2):92-8.
    View in: PubMed
    Score: 0.005
  23. Treatment strategies for locally recurrent rectal cancer. Eur J Surg Oncol. 2022 11; 48(11):2292-2298.
    View in: PubMed
    Score: 0.004
  24. Pathologic evaluation of total mesorectal excision: big brother is watching. J Clin Oncol. 2002 Apr 01; 20(7):1714-5.
    View in: PubMed
    Score: 0.004
  25. Germline Cancer Risk Profiles of Patients With Young-Onset Colorectal Cancer: Findings From a Prospective Universal Germline Testing and Telegenetics Program. Dis Colon Rectum. 2023 04 01; 66(4):531-542.
    View in: PubMed
    Score: 0.004
  26. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution. Oncologist. 2022 02 03; 27(1):40-47.
    View in: PubMed
    Score: 0.004
  27. Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local Recurrence. Clin Colorectal Cancer. 2022 09; 21(3):204-211.
    View in: PubMed
    Score: 0.004
  28. Healthy Moves to Improve Lifestyle Behaviors of Cancer Survivors and Their Spouses: Feasibility and Preliminary Results of Intervention Efficacy. Nutrients. 2021 Dec 14; 13(12).
    View in: PubMed
    Score: 0.004
  29. Early postoperative oral feeding after colectomy: an analysis of factors that may predict failure. Ann Surg Oncol. 2001 Dec; 8(10):796-800.
    View in: PubMed
    Score: 0.004
  30. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer. 2022 03; 21(1):e28-e37.
    View in: PubMed
    Score: 0.004
  31. Comment on "A National Cancer Database Analysis of Microsatellite Instability and Pathologic Complete Response in Locally Advanced Rectal Cancer". Ann Surg. 2021 08 01; 274(2):e197-e198.
    View in: PubMed
    Score: 0.004
  32. Fertility discussions in young adult stage III colorectal cancer population: a single-center institution experience. Support Care Cancer. 2021 Dec; 29(12):7351-7354.
    View in: PubMed
    Score: 0.004
  33. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol. 2001 May; 8(4):319-27.
    View in: PubMed
    Score: 0.004
  34. Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg. 2001 Mar; 181(3):207-10.
    View in: PubMed
    Score: 0.004
  35. Colorectal cancer: how does it start? How does it metastasize? Surg Oncol Clin N Am. 2000 Oct; 9(4):643-52; discussion 653-4.
    View in: PubMed
    Score: 0.004
  36. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation? Dis Colon Rectum. 2019 10; 62(10):1158-1166.
    View in: PubMed
    Score: 0.004
  37. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal. Clin Colorectal Cancer. 2019 12; 18(4):301-306.
    View in: PubMed
    Score: 0.003
  38. Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review. Fam Cancer. 2019 10; 18(4):399-420.
    View in: PubMed
    Score: 0.003
  39. Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancer. Cancer Genet. 2019 06; 235-236:77-83.
    View in: PubMed
    Score: 0.003
  40. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum. 2019 04; 62(4):429-437.
    View in: PubMed
    Score: 0.003
  41. Long-term survival in patients with ovarian metastases from colorectal carcinoma. Ann Surg Oncol. 1999 Apr-May; 6(3):322.
    View in: PubMed
    Score: 0.003
  42. Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features. Int J Cancer. 2019 05 01; 144(9):2161-2168.
    View in: PubMed
    Score: 0.003
  43. Correspondence re: C.R. Boland et al., A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58: 5248-5257, 1998. Cancer Res. 1999 Jan 01; 59(1):249-56.
    View in: PubMed
    Score: 0.003
  44. Cancer genetics and insurance. Am J Hum Genet. 1999 Jan; 64(1):328-9.
    View in: PubMed
    Score: 0.003
  45. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer. 1998 Jul 15; 83(2):240-4.
    View in: PubMed
    Score: 0.003
  46. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol. 2018 07; 41(7):632-637.
    View in: PubMed
    Score: 0.003
  47. Session 4: Shaping radiotherapy for rectal cancer: should this be personalized? Colorectal Dis. 2018 05; 20 Suppl 1:92-96.
    View in: PubMed
    Score: 0.003
  48. Health, life, and disability insurance and hereditary nonpolyposis colorectal cancer. Am J Hum Genet. 1998 Mar; 62(3):736-7.
    View in: PubMed
    Score: 0.003
  49. Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome. J Gastrointest Cancer. 2018 Mar; 49(1):93-96.
    View in: PubMed
    Score: 0.003
  50. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum. 2018 Jan; 61(1):77-83.
    View in: PubMed
    Score: 0.003
  51. Clinical features and survival of gastric cancer patients with DNA mismatch repair deficiency. J Surg Oncol. 2018 Mar; 117(4):707-709.
    View in: PubMed
    Score: 0.003
  52. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997 Dec 03; 89(23):1758-62.
    View in: PubMed
    Score: 0.003
  53. In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prev Res (Phila). 2017 Oct; 10(10):580-587.
    View in: PubMed
    Score: 0.003
  54. Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg. 1997 Jul; 84(7):1027-8.
    View in: PubMed
    Score: 0.003
  55. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome. Fam Cancer. 2017 07; 16(3):357-361.
    View in: PubMed
    Score: 0.003
  56. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol. 2017 Aug 10; 35(23):2631-2638.
    View in: PubMed
    Score: 0.003
  57. Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol. 2017 Jun; 40(3):277-282.
    View in: PubMed
    Score: 0.003
  58. Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy? Clin Cancer Res. 2017 Sep 01; 23(17):5246-5254.
    View in: PubMed
    Score: 0.003
  59. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Am J Clin Oncol. 2017 Apr; 40(2):163-166.
    View in: PubMed
    Score: 0.003
  60. Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis. Ann Surg Oncol. 2018 Jan; 25(1):32-37.
    View in: PubMed
    Score: 0.003
  61. A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers. Cancer Med. 2017 03; 6(3):698-707.
    View in: PubMed
    Score: 0.003
  62. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol. 2017 01; 122(1):146-151.
    View in: PubMed
    Score: 0.003
  63. Locally Recurrent Disease Related to Anal Canal Cancers. Surg Oncol Clin N Am. 2017 01; 26(1):115-125.
    View in: PubMed
    Score: 0.003
  64. A pilot study of cryochemotherapy for hepatic metastases from colorectal cancer. Cryobiology. 1996 Dec; 33(6):600-6.
    View in: PubMed
    Score: 0.003
  65. Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget. 2016 Nov 15; 7(46):76250-76260.
    View in: PubMed
    Score: 0.003
  66. Adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum. 1996 Nov; 39(11):1265-8.
    View in: PubMed
    Score: 0.003
  67. Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency. Fam Cancer. 2016 10; 15(4):587-91.
    View in: PubMed
    Score: 0.003
  68. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer. 2017 04 01; 123(7):1124-1133.
    View in: PubMed
    Score: 0.003
  69. Colorectal cancer in patients aged 30 years or younger. Surg Oncol. 1996 Aug; 5(4):189-94.
    View in: PubMed
    Score: 0.003
  70. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016 09 01; 34(25):3039-46.
    View in: PubMed
    Score: 0.003
  71. Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer. Has the time come? Cancer. 1996 Jul 15; 78(2):199-201.
    View in: PubMed
    Score: 0.003
  72. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum. 1996 Jun; 39(6):649-53.
    View in: PubMed
    Score: 0.003
  73. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg. 2016 May; 103(6):753-762.
    View in: PubMed
    Score: 0.003
  74. Clinical significance of colorectal cancer: metastases in lymph nodes < 5 mm in size. Ann Surg Oncol. 1996 Mar; 3(2):124-30.
    View in: PubMed
    Score: 0.003
  75. Pelvic exenteration and its modifications. Am J Surg. 1996 Feb; 171(2):293-8.
    View in: PubMed
    Score: 0.003
  76. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc. 2016 Jul; 84(1):115-125.e4.
    View in: PubMed
    Score: 0.003
  77. Intraoperative small bowel enteroscopy in familial adenomatous and familial juvenile polyposis. Gastrointest Endosc. 1995 Dec; 42(6):560-4.
    View in: PubMed
    Score: 0.003
  78. ACR Appropriateness Criteria? Local Excision in Early Stage Rectal Cancer. Am J Clin Oncol. 2015 Oct; 38(5):520-5.
    View in: PubMed
    Score: 0.003
  79. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. Oncologist. 2015 Nov; 20(11):1247-52.
    View in: PubMed
    Score: 0.003
  80. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer. J Clin Oncol. 2015 Nov 01; 33(31):3544-9.
    View in: PubMed
    Score: 0.003
  81. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer. J Natl Compr Canc Netw. 2015 Jul; 13(7):865-72.
    View in: PubMed
    Score: 0.003
  82. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 2015 May; 150(5):402-9.
    View in: PubMed
    Score: 0.003
  83. Reply to N.H. Turner et al and L. Dziki et al. J Clin Oncol. 2015 Apr 20; 33(12):1412-3.
    View in: PubMed
    Score: 0.003
  84. An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut. 2016 Feb; 65(2):286-95.
    View in: PubMed
    Score: 0.003
  85. Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surg. 2015 Mar 01; 150(3):245-51.
    View in: PubMed
    Score: 0.003
  86. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015 Jan; 150(1):17-22.
    View in: PubMed
    Score: 0.003
  87. The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal. Oncotarget. 2014 Nov 30; 5(22):11133-42.
    View in: PubMed
    Score: 0.003
  88. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genet. 2014 Oct-Dec; 207(10-12):495-502.
    View in: PubMed
    Score: 0.002
  89. ACR Appropriateness Criteria? rectal cancer: metastatic disease at presentation. Oncology (Williston Park). 2014 Oct; 28(10):867-71, 876, 878.
    View in: PubMed
    Score: 0.002
  90. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
    View in: PubMed
    Score: 0.002
  91. Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis. J Gastrointest Surg. 2015 Jan; 19(1):180-8; discussio 188.
    View in: PubMed
    Score: 0.002
  92. Desmoid tumors in patients with familial adenomatous polyposis. Cancer. 1994 Aug 15; 74(4):1270-4.
    View in: PubMed
    Score: 0.002
  93. Decompression of the large intestine in Ogilvie's syndrome by a colonoscopically placed long intestinal tube. Surg Endosc. 1994 Feb; 8(2):116-7.
    View in: PubMed
    Score: 0.002
  94. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. Surg Oncol. 1994 Feb; 3(1):27-36.
    View in: PubMed
    Score: 0.002
  95. Pelvic neuroanatomy and technique of abdominoperineal resection of the rectum for cancer. Arch Surg. 2004 Feb; 139(2):225; author reply 225.
    View in: PubMed
    Score: 0.002
  96. Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007. Cancer. 2014 Apr 15; 120(8):1162-70.
    View in: PubMed
    Score: 0.002
  97. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):301-5.
    View in: PubMed
    Score: 0.002
  98. Impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer. Ann Surg Oncol. 2014 Feb; 21(2):507-12.
    View in: PubMed
    Score: 0.002
  99. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer. 2013 Dec 15; 119(24):4231-41.
    View in: PubMed
    Score: 0.002
  100. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer. 2013 Nov 01; 119(21):3769-75.
    View in: PubMed
    Score: 0.002
  101. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013 Aug; 148(8):769-77.
    View in: PubMed
    Score: 0.002
  102. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon Rectum. 2013 May; 56(5):551-9.
    View in: PubMed
    Score: 0.002
  103. Metformin use and improved response to therapy in rectal cancer. Cancer Med. 2013 Feb; 2(1):99-107.
    View in: PubMed
    Score: 0.002
  104. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2013 Feb; 56(2):135-41.
    View in: PubMed
    Score: 0.002
  105. Global quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool. Gastrointest Endosc. 2013 Mar; 77(3):455-63.
    View in: PubMed
    Score: 0.002
  106. Problems encountered in teaching the use of the 65 cm flexible sigmoidoscope in a surgical oncology training program. J Cancer Educ. 1993; 8(3):213-6.
    View in: PubMed
    Score: 0.002
  107. Superior mesenteric artery syndrome after ileal pouch anal anastomosis. Am Surg. 2013 Jan; 79(1):E14-6.
    View in: PubMed
    Score: 0.002
  108. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum. 2012 Dec; 55(12):1213-9.
    View in: PubMed
    Score: 0.002
  109. 99mTc-IMMU-4 monoclonal antibody scan in colorectal cancer. A prospective study. Arch Surg. 1992 Nov; 127(11):1321-4.
    View in: PubMed
    Score: 0.002
  110. ACR appropriateness criteria???resectable rectal cancer. Radiat Oncol. 2012 Sep 24; 7:161.
    View in: PubMed
    Score: 0.002
  111. Prognostic significance of anastomotic recurrence from colorectal adenocarcinoma. Dis Colon Rectum. 1992 Sep; 35(9):838-42.
    View in: PubMed
    Score: 0.002
  112. Surgery for recurrent rectal adenocarcinoma in the presence of hydronephrosis. Am J Surg. 1992 Jul; 164(1):18-21.
    View in: PubMed
    Score: 0.002
  113. Technique for packing the perineal wound after a wide perineal dissection for adenocarcinoma of the rectum. Am Surg. 1992 May; 58(5):277-9.
    View in: PubMed
    Score: 0.002
  114. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012 May 20; 30(15):1770-6.
    View in: PubMed
    Score: 0.002
  115. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012 Sep; 19(9):2814-21.
    View in: PubMed
    Score: 0.002
  116. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Dis Colon Rectum. 2012 Apr; 55(4):371-7.
    View in: PubMed
    Score: 0.002
  117. Reverse-hybrid robotic mesorectal excision for rectal cancer. Dis Colon Rectum. 2012 Feb; 55(2):228-33.
    View in: PubMed
    Score: 0.002
  118. Intrathecal phenol rhizotomy for management of pain in recurrent unresectable carcinoma of the rectum. Surg Gynecol Obstet. 1991 Jul; 173(1):41-4.
    View in: PubMed
    Score: 0.002
  119. Feasibility of an expressive-disclosure group intervention for post-treatment colorectal cancer patients: results of the Healthy Expressions study. Cancer. 2011 Nov 01; 117(21):4993-5002.
    View in: PubMed
    Score: 0.002
  120. Benign parotid tumors: a 24-year experience. J Surg Oncol. 1991 Mar; 46(3):159-61.
    View in: PubMed
    Score: 0.002
  121. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer. 2011 Aug 15; 117(16):3713-22.
    View in: PubMed
    Score: 0.002
  122. Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2011 Apr; 18(4):989-96.
    View in: PubMed
    Score: 0.002
  123. Precancerous lesions of the digestive tract. The 18th Annual Symposium of the European Cancer Prevention Organization. Maastricht, The Netherlands. 12-14 October 2000. Abstracts. Eur J Cancer Prev. 2000 Dec; 9(6):443-63.
    View in: PubMed
    Score: 0.002
  124. Extraparotid Warthin's tumor: an unexpected finding in three female patients. N Y State J Med. 1990 Sep; 90(9):465-6.
    View in: PubMed
    Score: 0.002
  125. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010 Nov; 17(11):2863-9.
    View in: PubMed
    Score: 0.002
  126. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer. 2010 Jun; 9(2):99-107.
    View in: PubMed
    Score: 0.002
  127. Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer. 2010 Jun; 9(2):155-66.
    View in: PubMed
    Score: 0.002
  128. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010 Jun; 210(6):934-41.
    View in: PubMed
    Score: 0.002
  129. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer. 2009 Dec 01; 115(23):5432-40.
    View in: PubMed
    Score: 0.002
  130. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol. 2010 Feb; 17(2):441-7.
    View in: PubMed
    Score: 0.002
  131. Recurrent malignant salivary gland neoplasms. J Surg Oncol. 1989 Oct; 42(2):92-5.
    View in: PubMed
    Score: 0.002
  132. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):60-5.
    View in: PubMed
    Score: 0.002
  133. Management and outcomes of anorectal infection in the cancer patient. Ann Surg Oncol. 2009 Oct; 16(10):2752-8.
    View in: PubMed
    Score: 0.002
  134. Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience. Oncology. 2009; 77(2):75-81.
    View in: PubMed
    Score: 0.002
  135. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):818-23.
    View in: PubMed
    Score: 0.002
  136. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol. 2008 Nov 10; 26(32):5254-60.
    View in: PubMed
    Score: 0.002
  137. Re: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst. 1998 Jun 17; 90(12):939-40.
    View in: PubMed
    Score: 0.002
  138. Outcomes of immediate vertical rectus abdominis myocutaneous flap reconstruction for irradiated abdominoperineal resection defects. J Am Coll Surg. 2008 Apr; 206(4):694-703.
    View in: PubMed
    Score: 0.002
  139. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1175-80.
    View in: PubMed
    Score: 0.002
  140. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol. 2008 Jan 20; 26(3):368-73.
    View in: PubMed
    Score: 0.002
  141. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2008 Jan; 15(1):46-51.
    View in: PubMed
    Score: 0.002
  142. Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol. 2008 Jan-Feb; 26(1):9-16.
    View in: PubMed
    Score: 0.002
  143. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? J Clin Oncol. 2007 Aug 10; 25(23):3534-42.
    View in: PubMed
    Score: 0.002
  144. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007 May 01; 109(9):1750-5.
    View in: PubMed
    Score: 0.001
  145. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):794-800.
    View in: PubMed
    Score: 0.001
  146. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007 Mar 21; 99(6):433-41.
    View in: PubMed
    Score: 0.001
  147. Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis. 1997; 12(4):240-2.
    View in: PubMed
    Score: 0.001
  148. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol. 2007 Feb; 14(2):478-83.
    View in: PubMed
    Score: 0.001
  149. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):762-71.
    View in: PubMed
    Score: 0.001
  150. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1378-83.
    View in: PubMed
    Score: 0.001
  151. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Ann Surg Oncol. 2006 Oct; 13(10):1296-321.
    View in: PubMed
    Score: 0.001
  152. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol. 2006 Oct 01; 24(28):4642-60.
    View in: PubMed
    Score: 0.001
  153. Genomic profiles of colorectal cancers differ based on patient smoking status. Cancer Genet Cytogenet. 2006 Jul 15; 168(2):98-104.
    View in: PubMed
    Score: 0.001
  154. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006 Jun; 29(3):219-24.
    View in: PubMed
    Score: 0.001
  155. Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival? Am J Clin Oncol. 2006 Jun; 29(3):232-9.
    View in: PubMed
    Score: 0.001
  156. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):886-91.
    View in: PubMed
    Score: 0.001
  157. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006 Feb; 49(2):175-82.
    View in: PubMed
    Score: 0.001
  158. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 2006 Jan 18; 98(2):139-43.
    View in: PubMed
    Score: 0.001
  159. Staging intra-abdominal desmoid tumors in familial adenomatous polyposis: a search for a uniform approach to a troubling disease. Dis Colon Rectum. 2005 Aug; 48(8):1528-34.
    View in: PubMed
    Score: 0.001
  160. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States). Cancer Causes Control. 2005 Aug; 16(6):749-53.
    View in: PubMed
    Score: 0.001
  161. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate. 2005 Jan 01; 62(1):101-4.
    View in: PubMed
    Score: 0.001
  162. Analysis of inter-(simple sequence repeat) PCR products from human colorectal cancers. Oncol Res. 2005; 15(4):233-8.
    View in: PubMed
    Score: 0.001
  163. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1098-105.
    View in: PubMed
    Score: 0.001
  164. A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer. 2004 May 15; 100(10):2104-9.
    View in: PubMed
    Score: 0.001
  165. Surgical considerations in anal cancer. Surg Oncol Clin N Am. 2004 Apr; 13(2):321-38.
    View in: PubMed
    Score: 0.001
  166. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 Feb 18; 96(4):261-8.
    View in: PubMed
    Score: 0.001
  167. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004 Jan; 8(1):56-62; discussion 62-3.
    View in: PubMed
    Score: 0.001
  168. Perineal dissection of synchronous abdominoperineal resection of the rectum: an anatomical description. Arch Surg. 2003 May; 138(5):553-9.
    View in: PubMed
    Score: 0.001
  169. Chemoradiation for adenocarcinoma of the anus. Int J Radiat Oncol Biol Phys. 2003 Mar 01; 55(3):669-78.
    View in: PubMed
    Score: 0.001
  170. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer. 2003 Jan 15; 97(2):517-24.
    View in: PubMed
    Score: 0.001
  171. Is abdominoperineal resection a good option for stage IV adenocarcinoma of the distal rectum? J Surg Oncol. 2002 Sep; 81(1):3-7.
    View in: PubMed
    Score: 0.001
  172. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut. 2002 Jun; 50(6):857-60.
    View in: PubMed
    Score: 0.001
  173. Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis. 2002 Mar; 17(2):109-14.
    View in: PubMed
    Score: 0.001
  174. Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res. 2001 Nov 15; 61(22):8274-83.
    View in: PubMed
    Score: 0.001
  175. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer. 2001; 1(2):87-92.
    View in: PubMed
    Score: 0.001
  176. Local invasion of prostate carcinoma causing vesicorectal fistula. J Urol. 2000 Nov; 164(5):1662-3.
    View in: PubMed
    Score: 0.001
  177. Absorbable mesh sling prevents radiation-induced bowel injury during "sandwich" chemoradiation for rectal cancer. Arch Surg. 2000 Oct; 135(10):1212-7.
    View in: PubMed
    Score: 0.001
  178. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000 Jun 29; 342(26):1946-52.
    View in: PubMed
    Score: 0.001
  179. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut. 2000 May; 46(5):656-60.
    View in: PubMed
    Score: 0.001
  180. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma. Cancer. 2000 Apr 15; 88(8):1814-9.
    View in: PubMed
    Score: 0.001
  181. Photodynamic therapy for residual neoplasms of the perianal skin. Dis Colon Rectum. 2000 Apr; 43(4):499-502.
    View in: PubMed
    Score: 0.001
  182. Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg. 2000 Apr; 179(4):271-4.
    View in: PubMed
    Score: 0.001
  183. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A. 1999 Dec 21; 96(26):15121-6.
    View in: PubMed
    Score: 0.001
  184. Prevention of chronic radiation enteritis. J Am Coll Surg. 1999 Dec; 189(6):611-24.
    View in: PubMed
    Score: 0.001
  185. Disseminated peritoneal adenomucinosis: a critical review. Ann Surg Oncol. 1999 Dec; 6(8):797-801.
    View in: PubMed
    Score: 0.001
  186. Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome. Gut. 1999 Sep; 45(3):406-8.
    View in: PubMed
    Score: 0.001
  187. Large bowel adenocarcinoma metastases presenting as appendicitis. J Clin Oncol. 1999 Aug; 17(8):2623-4.
    View in: PubMed
    Score: 0.001
  188. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum. 1999 Jun; 42(6):710-5; discussion 715-6.
    View in: PubMed
    Score: 0.001
  189. Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum. 1999 Jun; 42(6):717-21.
    View in: PubMed
    Score: 0.001
  190. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA. 1999 Jun 23-30; 281(24):2316-20.
    View in: PubMed
    Score: 0.001
  191. Accuracy of biopsy and cytology for the preoperative diagnosis of colorectal adenocarcinoma. J Surg Oncol. 1999 May; 71(1):46-9.
    View in: PubMed
    Score: 0.001
  192. New approach to the substaging of node-positive colorectal adenocarcinoma. Ann Surg Oncol. 1999 Mar; 6(2):161-5.
    View in: PubMed
    Score: 0.001
  193. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer. 1999 Jan 18; 80(2):183-7.
    View in: PubMed
    Score: 0.001
  194. Utility of routine postoperative laboratory studies in patients undergoing potentially curative resection for adenocarcinoma of the colon and rectum. Cancer Invest. 1999; 17(2):102-9.
    View in: PubMed
    Score: 0.001
  195. Prognostic factors affecting survival in patients with colorectal carcinomatosis. Cancer Invest. 1999; 17(4):249-52.
    View in: PubMed
    Score: 0.001
  196. Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer. Cytogenet Cell Genet. 1999; 86(2):142-7.
    View in: PubMed
    Score: 0.001
  197. Long-term survival in patients with ovarian metastases from colorectal carcinoma. Ann Surg Oncol. 1998 Dec; 5(8):695-8.
    View in: PubMed
    Score: 0.001
  198. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998 Nov 15; 58(22):5248-57.
    View in: PubMed
    Score: 0.001
  199. Colovaginal anastomosis: a unique complication of end-to-end anastomosis stapler use in low anterior resection. Am Surg. 1998 Nov; 64(11):1023-6.
    View in: PubMed
    Score: 0.001
  200. Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet. 1998 Nov; 7(12):1907-12.
    View in: PubMed
    Score: 0.001
  201. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998 Jul 15; 83(2):259-66.
    View in: PubMed
    Score: 0.001
  202. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases. Cancer. 1998 Apr 01; 82(7):1244-9.
    View in: PubMed
    Score: 0.001
  203. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res. 1998 Mar 01; 58(5):997-1003.
    View in: PubMed
    Score: 0.001
  204. Absence of frequent involvement of modifier of Min(APC) in sporadic colorectal cancer. Ann Surg Oncol. 1998 Mar; 5(2):181-5.
    View in: PubMed
    Score: 0.001
  205. Intraoperative endoscopy in the management of patients with colorectal disease. Cancer Invest. 1998; 16(1):1-5.
    View in: PubMed
    Score: 0.001
  206. Anal canal and perianal epidermoid cancers. J Am Coll Surg. 1997 Nov; 185(5):494-505.
    View in: PubMed
    Score: 0.001
  207. Complications of absorbable pelvic mesh slings following surgery for rectal carcinoma. Dis Colon Rectum. 1997 Nov; 40(11):1336-41.
    View in: PubMed
    Score: 0.001
  208. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Cancer Res. 1997 Sep 01; 57(17):3798-803.
    View in: PubMed
    Score: 0.001
  209. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg. 1997 Feb; 225(2):202-7.
    View in: PubMed
    Score: 0.001
  210. Genomic instability in sporadic colorectal cancer quantitated by inter-simple sequence repeat PCR analysis. Genes Chromosomes Cancer. 1997 Jan; 18(1):19-29.
    View in: PubMed
    Score: 0.001
  211. p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers. J Natl Cancer Inst. 1996 Nov 20; 88(22):1665-70.
    View in: PubMed
    Score: 0.001
  212. Gastroduodenal polyps in familial adenomatous polyposis. Surg Endosc. 1996 Nov; 10(11):1118-9.
    View in: PubMed
    Score: 0.001
  213. The management of infectious and noninfectious anorectal complications in patients with leukemia. J Am Coll Surg. 1996 Oct; 183(4):322-8.
    View in: PubMed
    Score: 0.001
  214. Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery. Am J Surg. 1996 Sep; 172(3):299-302.
    View in: PubMed
    Score: 0.001
  215. Primary signet-ring cell carcinoma of the colon and rectum. Ann Surg Oncol. 1996 Jul; 3(4):344-8.
    View in: PubMed
    Score: 0.001
  216. Utility of mapping lymph nodes cleared from rectal adenocarcinoma specimens. Surg Oncol. 1996 Jun; 5(3):123-6.
    View in: PubMed
    Score: 0.001
  217. Desmoid tumors. J Am Coll Surg. 1996 Apr; 182(4):369-77.
    View in: PubMed
    Score: 0.001
  218. Postoperative complications after splenectomy for hematologic malignancies. Ann Surg. 1996 Mar; 223(3):290-6.
    View in: PubMed
    Score: 0.001
  219. Wide perineal dissection and its effect on local recurrence following potentially curative abdominoperineal resection for rectal adenocarcinoma. Cancer Invest. 1996; 14(1):1-5.
    View in: PubMed
    Score: 0.001
  220. A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer. Cancer Chemother Pharmacol. 1996; 37(6):581-6.
    View in: PubMed
    Score: 0.001
  221. Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. Cancer Invest. 1996; 14(5):491-7.
    View in: PubMed
    Score: 0.001
  222. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT. Radiology. 1995 Dec; 197(3):688-92.
    View in: PubMed
    Score: 0.001
  223. Intraoperative photodynamic therapy as an adjunct to surgery for recurrent rectal cancer. Ann Surg Oncol. 1995 May; 2(3):228-32.
    View in: PubMed
    Score: 0.001
  224. An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer. Cancer Res. 1995 Mar 01; 55(5):1122-8.
    View in: PubMed
    Score: 0.001
  225. The clinical and genetic manifestations of hereditary nonpolyposis colorectal carcinoma. Am J Surg. 1995 Mar; 169(3):368-72.
    View in: PubMed
    Score: 0.001
  226. Patterns of colorectal liver metastases according to Couinaud's segments. Dis Colon Rectum. 1995 Mar; 38(3):245-8.
    View in: PubMed
    Score: 0.001
  227. Prognosis and recurrence patterns of anal adenocarcinoma. Am J Surg. 1995 Feb; 169(2):233-7.
    View in: PubMed
    Score: 0.001
  228. A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinoma. Invest New Drugs. 1995; 13(2):149-55.
    View in: PubMed
    Score: 0.001
  229. Inguinal lymph node metastases from adenocarcinoma of the rectum. Am J Surg. 1994 Sep; 168(3):285-7.
    View in: PubMed
    Score: 0.001
  230. Primary colorectal non-Hodgkin's lymphoma. Ann Surg Oncol. 1994 May; 1(3):222-8.
    View in: PubMed
    Score: 0.001
  231. Phase I and pharmacokinetic evaluation of floxuridine/leucovorin given on the Roswell Park weekly regimen. Cancer Chemother Pharmacol. 1994; 34(3):261-5.
    View in: PubMed
    Score: 0.001
  232. Nasogastric decompression following elective colorectal surgery: a prospective randomized study. Am Surg. 1993 Oct; 59(10):632-5.
    View in: PubMed
    Score: 0.001
  233. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma. Cancer. 1993 Sep 01; 72(5):1543-6.
    View in: PubMed
    Score: 0.001
  234. Morbidity and mortality following abdominoperineal resection for rectal adenocarcinoma. Am Surg. 1993 Jul; 59(7):400-4.
    View in: PubMed
    Score: 0.001
  235. Primary adenocarcinoma arising in an ileostomy. Surgery. 1993 Jul; 114(1):125-8.
    View in: PubMed
    Score: 0.001
  236. Isolation of Inoue-Melnick virus from colorectal carcinoma tissues. Cancer. 1993 Mar 15; 71(6):1960-3.
    View in: PubMed
    Score: 0.001
  237. Altered immunoglobulin A (IgA-1) levels in patients with advanced colorectal adenocarcinoma presenting with normal preoperative levels of carcinoembryonic antigen (CEA). Surg Oncol. 1993; 2(1):19-23.
    View in: PubMed
    Score: 0.001
  238. Endoscopic laser treatment for palliation of colorectal adenocarcinoma. Surg Oncol. 1993; 2(1):25-30.
    View in: PubMed
    Score: 0.001
  239. Photodynamic therapy in the management of neoplasms of the perianal skin. Arch Surg. 1992 Dec; 127(12):1436-8.
    View in: PubMed
    Score: 0.001
  240. Gastroduodenal polyps in familial adenomatous polyposis. Surg Oncol. 1992 Oct; 1(5):357-61.
    View in: PubMed
    Score: 0.001
  241. The use of the major anoxic stress response protein P34, the K isozyme of lactate dehydrogenase, and carcinoembryonic antigen in the follow-up of patients with colorectal adenocarcinoma. Cancer. 1992 Oct 01; 70(7):1834-7.
    View in: PubMed
    Score: 0.001
  242. High prevalence of Inoue-Melnick virus antibodies in patients with colorectal carcinoma. Cancer Lett. 1992 Aug 31; 65(3):233-7.
    View in: PubMed
    Score: 0.001
  243. Papillary cystic neoplasm of the pancreas. A report of a case presenting with carcinomatosis. Am Surg. 1989 Sep; 55(9):552-9.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.